M3 launches Doctors.net.uk: ‘Pathway’ to Support International Medical Graduates Relocating to the UK’
M3 (EU) has announced the international launch of ‘Doctors.net.uk: Pathway’, the latest addition to Doctors.net.uk, the UK’s leading online community of more than 250,000 GMC-registered doctors. M3 (EU) recently unveiled the new, exclusive online platform, which is designed to provide…
Halozyme Announces Takeda Received European Commission Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Takeda received European Commission (EC) approval for HYQVIA® [Immune Globulin Infusion 10% (Human)] co-formulated with Halozyme’s ENHANZE® drug delivery technology as maintenance therapy in patients of all ages with chronic inflammatory demyelinating polyneuropathy (CIDP)…
INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSENTIAL TREMOR
Insightec, a pioneer and global leader in focused ultrasound, has welcomed a positive recommendation report[1] from the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) to have MR-guided focused ultrasound (MRgFUS) reimbursed for people suffering from essential tremor (ET). This recommendation is a…
Tarsier Pharma Announces Successful Type C Meeting with FDA for TRS01 in Noninfectious Uveitis
Tarsier Pharma, Ltd., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing first-in-class new therapies for the treatment of blinding ocular diseases, today announced the successful outcome of a Type C meeting with the U.S. Food and Drug Administration…
COSMOSS Partners With Chopra Foundation ‘Never Alone’ to Support Mental Health Awareness
Kate Moss, Founder of COSMOSS, and Deepak Chopra, Founder of Chopra Foundation, are proud to announce a new partnership to support mental health and wellbeing between COSMOSS and the Chopra Foundation. From January 2024, COSMOSS, the Award-Winning Wellness brand by…
Tampa General Hospital Named One of Newsweek’s Best Smart Hospitals for 2024
Tampa General Hospital (TGH) has been recognized as one of the World’s Best Smart Hospitals for 2024 by Newsweek and Statista. This prestigious global accolade is a testament to Tampa General’s commitment to harnessing cutting-edge technology to enable world-class patient…
MGI Partners with Gencell to Expand Genomics in Latin America
MGI, a company committed to building core tools and technology to lead life science, is thrilled to announce a strategic partnership with Gencell, a health company focused on molecular biology and genetic services in Colombia and the broader LATAM region….
Unlocking the Future of Drug Discovery with Artificial Intelligence
BCC’s newly released report, titled “Global Artificial Intelligence in Drug Discovery Market,” unveils the extraordinary impact of artificial intelligence (AI) on the pharmaceutical and biotech sectors. Authored by Ms. Surbhi Jagtap, Senior Analyst, this study provides invaluable insights into the…
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced positive topline results from the Phase 3 EV-302 clinical trial (also known as KEYNOTE-A39) for PADCEV® (enfortumab vedotin-ejfv) in combination with KEYTRUDA® (pembrolizumab)…
NYU Langone Health ranked No. 1 in the Nation for Quality and Patient Safety
NYU Langone Health has once again been named No. 1 in the nation for quality and patient safety by Vizient, Inc., a leading healthcare performance improvement organization that determines its rankings based on mortality and infection rates, patient experience scores,…